JP2022518743A5 - - Google Patents

Info

Publication number
JP2022518743A5
JP2022518743A5 JP2021542159A JP2021542159A JP2022518743A5 JP 2022518743 A5 JP2022518743 A5 JP 2022518743A5 JP 2021542159 A JP2021542159 A JP 2021542159A JP 2021542159 A JP2021542159 A JP 2021542159A JP 2022518743 A5 JP2022518743 A5 JP 2022518743A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
aryl
heterocyclyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021542159A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022518743A (ja
JP7550768B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/014658 external-priority patent/WO2020154437A1/en
Publication of JP2022518743A publication Critical patent/JP2022518743A/ja
Publication of JP2022518743A5 publication Critical patent/JP2022518743A5/ja
Priority to JP2024151730A priority Critical patent/JP7861064B2/ja
Application granted granted Critical
Publication of JP7550768B2 publication Critical patent/JP7550768B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021542159A 2019-01-23 2020-01-22 抗体-薬物コンジュゲート用のグリコシド含有ペプチドリンカー Active JP7550768B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024151730A JP7861064B2 (ja) 2019-01-23 2024-09-03 抗体-薬物コンジュゲート用のグリコシド含有ペプチドリンカー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962795875P 2019-01-23 2019-01-23
US62/795,875 2019-01-23
PCT/US2020/014658 WO2020154437A1 (en) 2019-01-23 2020-01-22 Glycoside-containing peptide linkers for antibody-drug conjugates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024151730A Division JP7861064B2 (ja) 2019-01-23 2024-09-03 抗体-薬物コンジュゲート用のグリコシド含有ペプチドリンカー

Publications (3)

Publication Number Publication Date
JP2022518743A JP2022518743A (ja) 2022-03-16
JP2022518743A5 true JP2022518743A5 (cg-RX-API-DMAC10.html) 2023-01-31
JP7550768B2 JP7550768B2 (ja) 2024-09-13

Family

ID=71736993

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021542159A Active JP7550768B2 (ja) 2019-01-23 2020-01-22 抗体-薬物コンジュゲート用のグリコシド含有ペプチドリンカー
JP2024151730A Active JP7861064B2 (ja) 2019-01-23 2024-09-03 抗体-薬物コンジュゲート用のグリコシド含有ペプチドリンカー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024151730A Active JP7861064B2 (ja) 2019-01-23 2024-09-03 抗体-薬物コンジュゲート用のグリコシド含有ペプチドリンカー

Country Status (8)

Country Link
US (1) US20220226490A1 (cg-RX-API-DMAC10.html)
EP (1) EP3914262A4 (cg-RX-API-DMAC10.html)
JP (2) JP7550768B2 (cg-RX-API-DMAC10.html)
KR (1) KR20210119450A (cg-RX-API-DMAC10.html)
CN (3) CN113874046B (cg-RX-API-DMAC10.html)
AU (1) AU2020210919B2 (cg-RX-API-DMAC10.html)
CA (1) CA3127098A1 (cg-RX-API-DMAC10.html)
WO (1) WO2020154437A1 (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020154437A1 (en) * 2019-01-23 2020-07-30 R.P. Scherer Technologies, Llc Glycoside-containing peptide linkers for antibody-drug conjugates
MX2023005979A (es) * 2020-11-20 2023-08-11 Scherer Technologies Llc R P Enlazadores de escisión doble de glicósido para conjugados de anticuerpo y fármaco.
CN116783208A (zh) * 2020-11-20 2023-09-19 R.P.谢勒技术有限责任公司 用于抗体-药物缀合物的糖苷双裂解接头
KR20230133312A (ko) * 2021-01-15 2023-09-19 알.피.쉐러 테크놀러지즈 엘엘씨 캄프토테신 항체-약물 접합체 및 이의 사용 방법
CN116847844A (zh) * 2021-01-15 2023-10-03 R.P.谢勒技术有限责任公司 喜树碱抗体-药物缀合物及其使用方法
MX2023008341A (es) * 2021-01-15 2023-10-04 Scherer Technologies Llc R P Enlazadores de ésteres de doble escisión para conjugados anticuerpo-fármaco.
EP4297798A4 (en) * 2021-02-25 2025-11-12 Allygen Group Targeting Conjugates Comprising Effector Molecules and Their Uses
KR20230165207A (ko) * 2021-03-03 2023-12-05 알.피.쉐러 테크놀러지즈 엘엘씨 항체-약물 접합체용 분지형 링커 및 이의 사용 방법
CN117279662A (zh) * 2021-03-03 2023-12-22 R.P.谢勒技术有限责任公司 用于抗体-药物缀合物的支链接头和其使用方法
KR20240040098A (ko) * 2021-07-30 2024-03-27 알.피.쉐러 테크놀러지즈 엘엘씨 넥틴-4에 특이적인 항체 및 항체 접합체 및 이의 사용방법
KR20250160368A (ko) * 2022-03-23 2025-11-12 알.피.쉐러 테크놀러지즈 엘엘씨 뮤신-1에 특이적인 항체 접합체 및 그의 사용 방법
AU2023396827A1 (en) 2022-12-13 2025-06-19 Crinetics Pharmaceuticals, Inc. Somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof
LT4601703T (lt) 2023-04-18 2026-06-25 Astrazeneca Ab Konjugatai, apimantys atskeliamuosius jungtukus
TW202525344A (zh) * 2023-08-15 2025-07-01 瑞典商阿斯特捷利康公司 包含可切割連接子的軛合物
WO2026024545A1 (en) * 2024-07-23 2026-01-29 R.P. Scherer Technologies Peg-carbamate linkers for antibody-drug conjugates and uses thereof
WO2026149165A1 (en) * 2025-01-08 2026-07-16 Beta Pharma, Inc. Novel maytansine derivatives, drug-linker conjugates, antibody conjugates and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2988786A4 (en) * 2013-04-22 2016-12-21 Avelas Biosciences Inc COMPOSITIONS FOR SELECTIVE DRUG ADMINISTRATION AND METHOD OF USE
CN115504924A (zh) * 2013-11-27 2022-12-23 雷德伍德生物科技股份有限公司 肼基-吡咯并化合物及用于生成缀合物的方法
WO2017083306A1 (en) * 2015-11-09 2017-05-18 R.P. Scherer Technologies, Llc Anti-cd22 antibody-maytansine conjugates and methods of use thereof
US10195283B2 (en) * 2016-03-18 2019-02-05 R.P. Scherer Technologies, Llc Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate
CN111065416B (zh) * 2017-06-21 2024-09-13 芬兰吉利科斯有限公司 亲水性接头及其共轭物
WO2019113248A1 (en) * 2017-12-07 2019-06-13 The Regents Of The University Of California Anti-upar antibody-drug conjugates and methods of use thereof
WO2020154437A1 (en) * 2019-01-23 2020-07-30 R.P. Scherer Technologies, Llc Glycoside-containing peptide linkers for antibody-drug conjugates

Similar Documents

Publication Publication Date Title
JP2019142870A5 (cg-RX-API-DMAC10.html)
JP7550768B2 (ja) 抗体-薬物コンジュゲート用のグリコシド含有ペプチドリンカー
TW306917B (cg-RX-API-DMAC10.html)
JP2024512986A5 (cg-RX-API-DMAC10.html)
IL306050A (en) Enzyme-triggered self-reacting linker having improved physicochemical and pharmacological properties
KR890003679A (ko) 시클릭 카르복실산 및 시클릭 알코올 및 아민의 에스테르와 아미드
JP2019501214A5 (cg-RX-API-DMAC10.html)
CS226408B2 (en) Method of preparing triiodinated diamides of isophtalic acid
JP2024529466A5 (cg-RX-API-DMAC10.html)
JP2023512687A (ja) IL-7Rα結合化合物
KR930004276A (ko) 치환된 헤테로사이클류
RU2007136535A (ru) Пептидомиметические соединения и получение биологически активных производных
RU2009121626A (ru) Соединения агонисты рецептора глюкагоноподобного белка-1 (glp-1r)
JP2024510927A5 (cg-RX-API-DMAC10.html)
JP2025516569A5 (cg-RX-API-DMAC10.html)
DE69329293D1 (de) Molekülmarkierung mit 2-hydrazinopyridinderivate
JP5602731B2 (ja) アーテミシニンの二量体誘導体および抗ガン療法における用途
JP2022534245A5 (cg-RX-API-DMAC10.html)
FR2788518A1 (fr) Nouveaux carbamates actives stables, leur procede de preparation et leur utilisation pour la preparation d'urees
HU226867B1 (en) Method for producing polymers having nucleo-bases as side-groups
JP2023551203A5 (cg-RX-API-DMAC10.html)
JPS60231690A (ja) N―置換ノイラミン酸誘導体
TWI439463B (zh) 青蒿素之二聚衍生物及其在抗癌治療之應用
RU2009130455A (ru) Введение радиоактивного изотопа путем фторирования азиридинов
JPWO2024043341A5 (cg-RX-API-DMAC10.html)